A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Clinical trial NCT03520998 · COMPLETED
Trial details
- NCT number
- NCT03520998
- Sponsor
- Alkahest, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-16
- Primary completion
- 2019-05-24
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.